MPS Pharmaa (BOM:531686) E10: ₹-1.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531686 MPS Pharmaa Ltd BOM:531686
11 GF Score
Price ₹1.99
! 3 Warning Signs
View Full Analysis

What is MPS Pharmaa E10?

MPS Pharmaa BOM:531686 +4.74% 11 E10 is ₹-1.36 as of Mar. 2026. GuruFocus rates BOM:531686 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

MPS Pharmaa's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹-0.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-1.36 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -4.80% per year. During the past 5 years, the average E10 Growth Rate was -10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of MPS Pharmaa was -4.80% per year. The lowest was -15.20% per year. And the median was -11.60% per year.

As of today (2026-08-11), MPS Pharmaa's current stock price is ₹1.99. MPS Pharmaa's E10 for the quarter that ended in Mar. 2026 was ₹-1.36. MPS Pharmaa's Shiller PE Ratio of today is .


MPS Pharmaa  (BOM:531686) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


MPS Pharmaa E10 Related Terms


MPS Pharmaa E10 Historical Data

* Premium members only.

The historical data trend for MPS Pharmaa's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPS Pharmaa E10 Chart

MPS Pharmaa Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.97 -1.18 -1.33 -1.35 -1.36

MPS Pharmaa Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.35 -1.33 -1.33 -1.32 -1.36

BOM:531686 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MPS Pharmaa's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPS Pharmaa Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPS Pharmaa's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MPS Pharmaa's Shiller PE Ratio falls into.


BOM:531686
11GF Score
MPS Pharmaa Ltd BOM:531686
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MPS Pharmaa E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MPS Pharmaa's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.19/164.2724*164.2724
=-0.190

Current CPI (Mar. 2026) = 164.2724.

MPS Pharmaa Quarterly Data

per share eps CPI Adj_EPS
201606 -2.120 105.961 -3.287
201609 -0.160 105.961 -0.248
201612 -0.120 105.196 -0.187
201703 -1.480 105.196 -2.311
201706 -0.120 107.109 -0.184
201709 -0.110 109.021 -0.166
201712 -0.110 109.404 -0.165
201803 -0.110 109.786 -0.165
201806 -0.170 111.317 -0.251
201809 -0.160 115.142 -0.228
201812 -0.150 115.142 -0.214
201903 -0.170 118.202 -0.236
201906 -0.140 120.880 -0.190
201909 -0.140 123.175 -0.187
201912 -0.130 126.235 -0.169
202003 -0.190 124.705 -0.250
202006 -0.140 127.000 -0.181
202009 -0.140 130.118 -0.177
202012 -1.950 130.889 -2.447
202103 -0.080 131.771 -0.100
202106 -0.150 134.084 -0.184
202109 -0.010 135.847 -0.012
202112 -0.140 138.161 -0.166
202203 0.230 138.822 0.272
202206 -0.110 142.347 -0.127
202209 -0.140 144.661 -0.159
202212 -0.140 145.763 -0.158
202303 -0.170 146.865 -0.190
202306 -0.100 150.280 -0.109
202309 -0.100 151.492 -0.108
202312 -0.110 152.924 -0.118
202403 -0.120 153.035 -0.129
202406 -0.120 155.789 -0.127
202409 -0.120 157.882 -0.125
202412 -0.090 158.323 -0.093
202503 -0.150 157.552 -0.156
202506 -0.120 159.755 -0.123
202509 -0.120 162.289 -0.121
202512 -0.120 163.281 -0.121
202603 -0.190 164.272 -0.190

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹-1.36 mean?
MPS Pharmaa (BOM:531686) has a E10 of ₹-1.36 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on MPS Pharmaa and its competitors.
Is MPS Pharmaa's E10 too high?
MPS Pharmaa's current E10 is ₹-1.36. Overall, MPS Pharmaa has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does MPS Pharmaa's E10 compare to ZTS?
MPS Pharmaa's E10 of ₹-1.36 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on MPS Pharmaa and its competitors. MPS Pharmaa's current E10 is ₹-1.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPS Pharmaa stock overvalued right now?
MPS Pharmaa (BOM:531686) has a current E10 of ₹-1.36. The current E10 is ₹-1.36. MPS Pharmaa's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For MPS Pharmaa (BOM:531686), the current E10 is ₹-1.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPS Pharmaa Business Description

Address 19 Barakhamba Road, Connaught Place, 703, Arunachal Building, New Delhi, IND, 110001
MPS Pharmaa Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing, marketing, trading, and exporting Pharmaceutical Products. The company manufactures and exports medicines that include antihypertensive medicines, antihypertensive tablets, antifungal tablets, antifungal capsules, erectile dysfunction drugs, sedatives, corticosteroid medicines, antimalarials, anthelmintics, antipyretic & anti-inflammatory, and antibacterials & antibiotics. Its products include Wibatol, Robial, Twosum, Arfa Gel, and others.
11GF Score

Get the complete analysis for BOM:531686

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.99
Price